AK

Asif Khan

Active Director Director DIN 11197256
DIN 11197256 First appointment Jul 2025 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jul 2025
Shareholding value Locked Premium profile

About Asif Khan

Asif Khan has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Orvantix Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 11197256
Primary Designation Director
First Appointment 16 Jul 2025
Oldest Company Age 1 yrs

Current companies

Company Designation Appointment Founded Status
Orvantix Pharma Private Limited U47720UP2025PTC227965
Director 16 Jul 2025 2025 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Orvantix Pharma Private Limited
Premium access

Shareholding and investment profile for Asif Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asif Khan

Asif Khan has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Orvantix Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Asif Khan is associated with 1 company as Director.

Asif Khan has expertise in General Business.

Asif Khan has 1 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available